Keraflex® and the Vedera™ KXS
Expanding the market potential for the correction of myopia, and the treatment of keratoconus, using a non-surgical and non-incisional procedure.
The Keraflex® procedure, performed with the Vedera™ KXS, is currently in clinical trials in Europe for the correction of myopia and other refractive disorders, and for the treatment of keratoconus. Avedro plans to file for an FDA IDE in the United States in mid-2010.
This non-incisional procedure expands the eligibility criteria for people seeking refractive correction and overcomes the current barriers to broader adoption of laser vision correction, especially among people with low and moderate myopia.
In the treatment of keratoconus, preservation of the biomechanical integrity of the cornea and the ability to effect refractive change similarly hold promise for improving disease management.
Learn more about the Keraflex procedure and the Vedera KXS.
The Vedera KXS is undergoing European clinical studies and is not currently available for sale.